Cargando…
The response of total testing process in clinical laboratory medicine to COVID-19 pandemic
INTRODUCTION: Following a pandemic, laboratory medicine is vulnerable to laboratory errors due to the stressful and high workloads. We aimed to examine how laboratory errors may arise from factors, e.g., flexible working order, staff displacement, changes in the number of tests, and samples will ref...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183122/ https://www.ncbi.nlm.nih.gov/pubmed/34140836 http://dx.doi.org/10.11613/BM.2021.020713 |
_version_ | 1783704324284612608 |
---|---|
author | Eren, Funda Tuncay, Merve Ergin Oguz, Esra Firat Neselioglu, Salim Erel, Ozcan |
author_facet | Eren, Funda Tuncay, Merve Ergin Oguz, Esra Firat Neselioglu, Salim Erel, Ozcan |
author_sort | Eren, Funda |
collection | PubMed |
description | INTRODUCTION: Following a pandemic, laboratory medicine is vulnerable to laboratory errors due to the stressful and high workloads. We aimed to examine how laboratory errors may arise from factors, e.g., flexible working order, staff displacement, changes in the number of tests, and samples will reflect on the total test process (TTP) during the pandemic period. MATERIALS AND METHODS: In 12 months, 6 months before and during the pandemic, laboratory errors were assessed via quality indicators (QIs) related to TTP phases. QIs were grouped as pre-, intra- and postanalytical. The results of QIs were expressed in defect percentages and sigma, evaluated with 3 levels of performance quality: 25(th), 50(th) and 75(th) percentile values. RESULTS: When the pre- and during pandemic periods were compared, the sigma value of the samples not received was significantly lower in pre-pandemic group than during pandemic group (4.7σ vs. 5.4σ, P = 0.003). The sigma values of samples transported inappropriately and haemolysed samples were significantly higher in pre-pandemic period than during pandemic (5.0σ vs. 4.9σ, 4.3σ vs. 4.1σ; P = 0.046 and P = 0.044, respectively). Sigma value of tests with inappropriate IQC performances was lower during pandemic compared to the pre-pandemic period (3.3σ vs. 3.2σ, P = 0.081). Sigma value of the reports delivered outside the specified time was higher during pandemic than pre-pandemic period (3.0σ vs. 3.1σ, P = 0.030). CONCLUSION: In all TTP phases, some quality indicators improved while others regressed during the pandemic period. It was observed that preanalytical phase was affected more by the pandemic. |
format | Online Article Text |
id | pubmed-8183122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Croatian Society of Medical Biochemistry and Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-81831222021-06-16 The response of total testing process in clinical laboratory medicine to COVID-19
pandemic Eren, Funda Tuncay, Merve Ergin Oguz, Esra Firat Neselioglu, Salim Erel, Ozcan Biochem Med (Zagreb) Original Articles INTRODUCTION: Following a pandemic, laboratory medicine is vulnerable to laboratory errors due to the stressful and high workloads. We aimed to examine how laboratory errors may arise from factors, e.g., flexible working order, staff displacement, changes in the number of tests, and samples will reflect on the total test process (TTP) during the pandemic period. MATERIALS AND METHODS: In 12 months, 6 months before and during the pandemic, laboratory errors were assessed via quality indicators (QIs) related to TTP phases. QIs were grouped as pre-, intra- and postanalytical. The results of QIs were expressed in defect percentages and sigma, evaluated with 3 levels of performance quality: 25(th), 50(th) and 75(th) percentile values. RESULTS: When the pre- and during pandemic periods were compared, the sigma value of the samples not received was significantly lower in pre-pandemic group than during pandemic group (4.7σ vs. 5.4σ, P = 0.003). The sigma values of samples transported inappropriately and haemolysed samples were significantly higher in pre-pandemic period than during pandemic (5.0σ vs. 4.9σ, 4.3σ vs. 4.1σ; P = 0.046 and P = 0.044, respectively). Sigma value of tests with inappropriate IQC performances was lower during pandemic compared to the pre-pandemic period (3.3σ vs. 3.2σ, P = 0.081). Sigma value of the reports delivered outside the specified time was higher during pandemic than pre-pandemic period (3.0σ vs. 3.1σ, P = 0.030). CONCLUSION: In all TTP phases, some quality indicators improved while others regressed during the pandemic period. It was observed that preanalytical phase was affected more by the pandemic. Croatian Society of Medical Biochemistry and Laboratory Medicine 2021-06-15 2021-06-15 /pmc/articles/PMC8183122/ /pubmed/34140836 http://dx.doi.org/10.11613/BM.2021.020713 Text en Croatian Society of Medical Biochemistry and Laboratory Medicine. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Eren, Funda Tuncay, Merve Ergin Oguz, Esra Firat Neselioglu, Salim Erel, Ozcan The response of total testing process in clinical laboratory medicine to COVID-19 pandemic |
title | The response of total testing process in clinical laboratory medicine to COVID-19
pandemic |
title_full | The response of total testing process in clinical laboratory medicine to COVID-19
pandemic |
title_fullStr | The response of total testing process in clinical laboratory medicine to COVID-19
pandemic |
title_full_unstemmed | The response of total testing process in clinical laboratory medicine to COVID-19
pandemic |
title_short | The response of total testing process in clinical laboratory medicine to COVID-19
pandemic |
title_sort | response of total testing process in clinical laboratory medicine to covid-19
pandemic |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183122/ https://www.ncbi.nlm.nih.gov/pubmed/34140836 http://dx.doi.org/10.11613/BM.2021.020713 |
work_keys_str_mv | AT erenfunda theresponseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT tuncaymerveergin theresponseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT oguzesrafirat theresponseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT neselioglusalim theresponseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT erelozcan theresponseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT erenfunda responseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT tuncaymerveergin responseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT oguzesrafirat responseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT neselioglusalim responseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic AT erelozcan responseoftotaltestingprocessinclinicallaboratorymedicinetocovid19pandemic |